A fully biodegradable polydioxanone occluder for ventricle septal defect closure
Open Access
- 1 June 2023
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 24, 252-262
Abstract
Ventricular septal defect (VSD) is one of the commonest congenital heart diseases (CHDs). Current occluders for VSD treatment are mainly made of nitinol, which has the risk of nickel allergy, persistent myocardial abrasion and fatal arrythmia. Herein, a fully biodegradable polydioxanone (PDO) occluder equipped with a shape line and poly-l-lactic acid PLLA membranes is developed for VSD closure without the addition of metal marker. PDO occluder showed great mechanical strength, fatigue resistance, geometry fitness, biocompatibility and degradability. In a rat subcutaneous implantation model, PDO filaments significantly alleviated inflammation response, mitigated fibrosis and promoted endothelialization compared with nitinol. The safety and efficacy of PDO occluder were confirmed in a canine VSD model with 3-year follow-up, demonstrating the biodegradable PDO occluder could not only effectively repair VSD, induce cardiac remodeling but also address the complications associated with metal occluders. Furthermore, a pilot clinical trial with five VSD patients indicated that all the occluders were successfully implanted under the guidance of echocardiography and no adverse events occurred during the 3-month follow-up. Collectively, the fully bioresorbable PDO occluder is safe and effective for clinical VSD closure and holds great promise for the treatment of structural CHDs.Keywords
Funding Information
- Sanming Project of Medicine in Shenzen Municipality (SZSM202011013)
- Fundamental Research Funds for the Central Universities (2019PT350005)
- Science Fund for Distinguished Young Scholars of Tianjin Municipality (21JCJQJC00020)
- National Natural Science Foundation of China (81970444)
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (2020-RSW02, Z201100005420030)
- Chinese Academy of Medical Sciences (2021-I2M-1–058, 2021-I2M-1–065)
This publication has 33 references indexed in Scilit:
- Tissue-engineered bone formation using periosteal-derived cells and polydioxanone/pluronic F127 scaffold with pre-seeded adipose tissue-derived CD146 positive endothelial-like cellsBiomaterials, 2011
- The changing epidemiology of congenital heart diseaseNature Reviews Cardiology, 2010
- A polydioxanone electrospun valved patch to replace the right ventricular outflow tract in a growing lamb modelBiomaterials, 2010
- Biodisk: A new device for closure of patent foramen ovale: A feasibility study in swineCatheterization and Cardiovascular Interventions, 2010
- Chest wall reconstruction in a canine model using polydioxanone mesh, demineralized bone matrix and bone marrow stromal cellsBiomaterials, 2009
- Transcatheter closure of perimembranous ventricular septal defect: Figure 1Heart, 2007
- BioSTAR Evaluation STudy (BEST)Circulation, 2006
- Interventional Atrial Septal Defect Closure Using a Totally Bioresorbable Occluder MatrixJACC, 2006
- Preparation and physicochemical characterization of biodegradable nerve guides containing the nerve growth agent sabeluzoleBiomaterials, 2005
- Heat capacity of poly-p-dioxanoneJournal of Macromolecular Science, Part B, 1998